Crossbow Therapeutics is a biotechnology company developing novel antibody therapeutics for cancer treatment, with a focus on TCR-mimetic antibodies. The website describes their mission to expand the reach of antibody therapies. The company has raised $77 million in Series B financing as reported in recent news.
Filed April 30, 2025 · Manhattan, NY
Your competitors in Manhattan are getting unlimited new business leads.
CROSSBOW THERAPEUTICS, INC. is a biotechnology business (Corp) registered on April 30, 2025 with the New York Division of Corporations. The business is located in Manhattan, New York.
Get owner name, phone, email, and website for newly registered businesses delivered to your inbox daily.
Start Your Free Trial ›Filing timeline will be available soon.
CROSSBOW THERAPEUTICS, INC. was registered as Corp on April 30, 2025 in New York.
CROSSBOW THERAPEUTICS, INC.'s principal address on file is Manhattan, NY, 122072543.
CROSSBOW THERAPEUTICS, INC. is classified as a biotechnology business (antibody therapeutics).
No EIN was found on file for CROSSBOW THERAPEUTICS, INC. at the time of registration.
Based on the business category, these service providers typically target this type of business.